Huahai Pharmaceutical announces convertible bond put option period
Zhejiang Huahai Pharmaceutical Co., Ltd. has announced an optional put option for its "Huahai convertible bonds" (bond code: 110076). The put option period will run from December 22, 2025, to December 26, 2025, with put proceeds disbursed on December 31, 2025. During this period, the bonds will cease to be convertible into shares.
The put price is set at CNY 100.30 per bond, inclusive of accrued interest and tax. This price is based on the sixth-year coupon rate of 2.00% and an interest calculation period of 54 days (from November 2, 2025, to December 26, 2025). The company's stock closing price has been below 70% of the current conversion price for 30 consecutive trading days, triggering the put option.
Bondholders can choose to tender all or part of their unconverted bonds. The company warns that if the "Huahai convertible bond" closing price is higher than the put price on the last trading day before this announcement, bondholders opting to put their bonds may incur losses.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime